Smith & Nephew (SNN) Change in Working Capital (2009 - 2018)
Smith & Nephew (SNN) posted quarterly Change in Working Capital of -$1.0 million for Q4 2018, up 99.92% year-on-year from -$500195.2 in Q4 2017, and up 99.92% on a QoQ basis from -$1.3 billion in Q4 2017.
Smith & Nephew (SNN) Change in Working Capital (2009 - 2018) Analysis & Trends
Smith & Nephew (SNN) has reported Change in Working Capital for 9 consecutive years, with -$1.0 million the latest figure, recorded in Q4 2018.
- Quarterly Change in Working Capital rose 99.92% year-over-year to -$1.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was -$419.0 million (changed 0.24% YoY) and the FY2020 annual result came in at -$128.0 million, up 9.22% from the prior year.
- Change in Working Capital improved to -$1.0 million in Q4 2018 per SNN's latest filing, from -$1.3 billion in the prior quarter.
- Over the last five years, Change in Working Capital for SNN reached as high as $13.5 billion in Q4 2014 and fell as low as -$1.6 billion in Q4 2016.
- A 5-year average of $1.9 billion and a median of -$1.0 million in 2018 frame the typical range for Change in Working Capital.
- Annual changes were most pronounced in 2014 — Change in Working Capital jumped 113.96% — and 2016, when it slumped 164.24%.
- Year by year, Change in Working Capital stood at $13.5 billion in 2014, then sank by 82.08% to $2.4 billion in 2015, then tumbled by 164.24% to -$1.6 billion in 2016, then increased by 17.35% to -$1.3 billion in 2017, then surged by 99.92% to -$1.0 million in 2018.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$1.0 million, -$1.3 billion, and -$1.6 billion for Q4 2018, Q4 2017, and Q4 2016 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -128.78 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -1.00 Mn |
| Dec 31, 2018 | -1.00 Mn |
| Dec 31, 2017 | -1.28 Bn |
| Dec 31, 2017 | -1.28 Bn |
| Dec 31, 2016 | -1.55 Bn |
| Dec 31, 2016 | -1.55 Bn |
| Dec 31, 2015 | 2.41 Bn |
| Dec 31, 2015 | 2.41 Bn |
| Jun 30, 2015 | -2.00 Mn |
| Jun 30, 2015 | -2.00 Mn |
| Dec 31, 2014 | 13.47 Bn |
| Dec 31, 2014 | 13.47 Bn |
| Sep 30, 2014 | 31.00 Mn |
| Sep 30, 2014 | 31.00 Mn |
| Dec 31, 2013 | 11.04 Bn |
| Dec 31, 2013 | 11.04 Bn |
| Sep 28, 2013 | -222.00 Mn |
| Sep 28, 2013 | -222.00 Mn |
| Jun 29, 2013 | -281.00 Mn |
| Jun 29, 2013 | -281.00 Mn |